Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma.
Invest New Drugs
; 38(2): 402-409, 2020 04.
Article
em En
| MEDLINE
| ID: mdl-30953269
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Benzazepinas
/
Carcinoma Adenoide Cístico
/
Receptor Notch1
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article